Although the Centers for Disease Control and Prevention (CDC) estimates that just over a million people are at sufficient risk of HIV to meet pre-exposure prophylaxis (PrEP) prescribing guidelines, less than one in ten of these individuals are taking PrEP. What's more, the uptake of PrEP has...
PrEP (pre-exposure prophylaxis) is a medication that can help prevent you from getting HIV. HIV is a virus that attacks the body’s immune system. While it can be treated, there is no known cure, making prevention very important. There are now 3 approved PrEP medications in the US—2 a...
In the June 11, 2019, issue ofJAMA,the US Preventive Services Task Force (USPSTF) updates its 2013 recommendations on HIV screening and issues its first published guidance on the prevention of HIV infection with preexposure prophylaxis (PrEP).1-7As in 2013, the USPSTF provides a grade A rec...
Pre-exposure prophylaxis—or PrEP for short—is the term for the use of HIV medications to prevent an HIV infection before it occurs. It has been a strategy approved in the United States since 2012, when the U.S. Food and Drug Administration approved the pill Truvada for use as PrEP. Si...
PrEP Prevents HIV -- So Where Are the Prescriptions for Women, Sex Workers and Drug Users?Heather Boerner
In closing, you can make a big difference in reducing new HIV infections in the United States in 2 ways: •By assisting those at high risk for HIV to obtain access to prevention information, condoms, drug treatment and PrEP, if indicated; and ...
1)PrEP是日常使用抗病毒药物预防HIV感染的方法,它可以帮助人们享受更安全的性生活。 2) PrEP适用于未感染HIV但感染风险高的人群。 3) PrEP已经被证实可安全、有效地预防HIV感染,且在多个国家已经投入实际应用。PrEP还有利于引起使用者对整体身心健康的关注。
总而言之,CROPrEP证实PrEP在中国MSM人群中可有效降低HIV感染风险,为我国PrEP指南及相关政策的指定提供了重要依据。 获取更多肝炎、艾滋病、抗真菌领域最新文献、指南与前沿资讯,与AI医学助手“晓智”互动 欢迎关注“吉智医” 参考文献: [1]WHO. Guidance on Pre-exposure oral prophylaxis (PrEP) for serodiscordant ...
CLINICIANS’ QUICK GUIDE The US Food and Drug Administration (FDA) has approved one injectable pre-exposure prophylaxis (PrEP) medication: cabotegravir (CAB) 600 mg (brand name Apretude®). CAB is a single antiretroviral drug given as an intramuscular injection every 2 months to prevent HIV.
Lisbon MSM cohort study estimates point that 59.3% of their participants at entrance (1593 HIV negative MSM enrolled between April 2011 and May 2013) were eligible for PrEP [2], according to the 2014 USA PrEP guidelines [3]. Studies about PrEP acceptability......